The influence of the European Research Initiative on CLL (ERIC)
Why should young investigators join the CLL community?
Constantine Tam et al.
Current research to overcome T-cell dysfunction in CLL and improve therapies
MAJIC trial results: ruxolitinib compared to best available therapy for essential thrombocythemia
Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor